191 related articles for article (PubMed ID: 31981880)
1. Quality of life assessment and reporting in colorectal cancer: A systematic review of phase III trials published between 2012 and 2018.
Lombardi P; Marandino L; De Luca E; Zichi C; Reale ML; Pignataro D; Di Stefano RF; Ghisoni E; Mariniello A; Trevisi E; Leone G; Muratori L; La Salvia A; Sonetto C; Leone F; Aglietta M; Novello S; Scagliotti GV; Perrone F; Di Maio M
Crit Rev Oncol Hematol; 2020 Feb; 146():102877. PubMed ID: 31981880
[TBL] [Abstract][Full Text] [Related]
2. Quality of life analysis in lung cancer: A systematic review of phase III trials published between 2012 and 2018.
Reale ML; De Luca E; Lombardi P; Marandino L; Zichi C; Pignataro D; Ghisoni E; Di Stefano RF; Mariniello A; Trevisi E; Leone G; Muratori L; La Salvia A; Sonetto C; Bironzo P; Aglietta M; Novello S; Scagliotti GV; Perrone F; Di Maio M
Lung Cancer; 2020 Jan; 139():47-54. PubMed ID: 31734586
[TBL] [Abstract][Full Text] [Related]
3. Deficiencies in health-related quality-of-life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016.
Marandino L; La Salvia A; Sonetto C; De Luca E; Pignataro D; Zichi C; Di Stefano RF; Ghisoni E; Lombardi P; Mariniello A; Reale ML; Trevisi E; Leone G; Muratori L; Marcato M; Bironzo P; Novello S; Aglietta M; Scagliotti GV; Perrone F; Di Maio M
Ann Oncol; 2018 Dec; 29(12):2288-2295. PubMed ID: 30304498
[TBL] [Abstract][Full Text] [Related]
4. Quality-of-Life Assessment and Reporting in Prostate Cancer: Systematic Review of Phase 3 Trials Testing Anticancer Drugs Published Between 2012 and 2018.
Marandino L; De Luca E; Zichi C; Lombardi P; Reale ML; Pignataro D; Di Stefano RF; Ghisoni E; Mariniello A; Trevisi E; Leone G; Muratori L; La Salvia A; Sonetto C; Buttigliero C; Tucci M; Aglietta M; Novello S; Scagliotti GV; Perrone F; Di Maio M
Clin Genitourin Cancer; 2019 Oct; 17(5):332-347.e2. PubMed ID: 31416754
[TBL] [Abstract][Full Text] [Related]
5. Challenges posed by non-random missing quality of life data in an advanced-stage colorectal cancer clinical trial.
Moinpour CM; Sawyers Triplett J; McKnight B; Lovato LC; Upchurch C; Leichman CG; Muggia FM; Tanaka L; James WA; Lennard M; Meyskens FL
Psychooncology; 2000; 9(4):340-54. PubMed ID: 10960931
[TBL] [Abstract][Full Text] [Related]
6. A Systematic Review of Health-Related Quality of Life Reporting in Ovarian Cancer Phase III Clinical Trials: Room to Improve.
Wilson MK; Friedlander ML; Joly F; Oza AM
Oncologist; 2018 Feb; 23(2):203-213. PubMed ID: 29118265
[TBL] [Abstract][Full Text] [Related]
7. The impact of chemotherapy on overall survival and quality of life of patients with metastatic colorectal cancer: a review of phase III trials.
Funaioli C; Longobardi C; Martoni AA
J Chemother; 2008 Feb; 20(1):14-27. PubMed ID: 18343739
[TBL] [Abstract][Full Text] [Related]
8. Quality of life versus prolongation of life in patients treated with chemotherapy in advanced colorectal cancer: A review of randomized controlled clinical trials.
de Kort SJ; Willemse PH; Habraken JM; de Haes HC; Willems DL; Richel DJ
Eur J Cancer; 2006 May; 42(7):835-45. PubMed ID: 16481158
[TBL] [Abstract][Full Text] [Related]
9. High symptom burden is associated with impaired quality of life in colorectal cancer patients during chemotherapy:A prospective longitudinal study.
Röhrl K; Guren MG; Astrup GL; Småstuen MC; Rustøen T
Eur J Oncol Nurs; 2020 Feb; 44():101679. PubMed ID: 31751848
[TBL] [Abstract][Full Text] [Related]
10. Does severe toxicity affect global quality of life in patients with metastatic colorectal cancer during palliative systemic treatment? A systematic review.
Schuurhuizen CSEW; Braamse AMJ; Konings IRHM; Sprangers MAG; Ket JCF; Dekker J; Verheul HMW
Ann Oncol; 2017 Mar; 28(3):478-486. PubMed ID: 27998965
[TBL] [Abstract][Full Text] [Related]
11. Systematic review of adoption, reporting and impact of health-related quality of life in phase III non-inferiority trials of systemic oncology treatments.
Notarnicola S; Zumstein L; Paparo J; Marandino L; Perrone F; Di Maio M
Eur J Cancer; 2023 Dec; 195():113374. PubMed ID: 38557561
[TBL] [Abstract][Full Text] [Related]
12. Health-related quality of life assessment in contemporary phase III trials in advanced colorectal cancer.
Adamowicz K; Saad ED; Jassem J
Cancer Treat Rev; 2016 Nov; 50():194-199. PubMed ID: 27718458
[TBL] [Abstract][Full Text] [Related]
13. Associations between safety, tolerability, and toxicity and the reporting of health-related quality of life in phase III randomized trials in common solid tumors.
Saleh RR; Meti N; Ribnikar D; Goldvaser H; Ocana A; Templeton AJ; Seruga B; Amir E
Cancer Med; 2020 Nov; 9(21):7888-7895. PubMed ID: 32886422
[TBL] [Abstract][Full Text] [Related]
14. Quality of life assessment in renal cell carcinoma Phase II and III clinical trials published between 2010 and 2020: a systematic review.
Rizzo A; Mollica V; Dall'Olio FG; Ricci AD; Maggio I; Marchetti A; Rosellini M; Santoni M; Ardizzoni A; Massari F
Future Oncol; 2021 Jul; 17(20):2671-2681. PubMed ID: 33880963
[TBL] [Abstract][Full Text] [Related]
15. A systematic review of the use of quality of life measures in colorectal cancer research with attention to outcomes in elderly patients.
Sanoff HK; Goldberg RM; Pignone MP
Clin Colorectal Cancer; 2007 Nov; 6(10):700-9. PubMed ID: 18039423
[TBL] [Abstract][Full Text] [Related]
16. Assessment of quality of life in advanced, metastatic prostate cancer: an overview of randomized phase III trials.
Adamowicz K
Qual Life Res; 2017 Apr; 26(4):813-822. PubMed ID: 27738867
[TBL] [Abstract][Full Text] [Related]
17. Moving Beyond Conventional Clinical Trial End Points in Treatment-refractory Metastatic Colorectal Cancer: A Composite Quality-of-life and Symptom Control End Point.
Gong J; Wu D; Chuang J; Tuli R; Simard J; Hendifar A
Clin Ther; 2017 Nov; 39(11):2135-2145. PubMed ID: 29079389
[TBL] [Abstract][Full Text] [Related]
18. Inadequate health-related quality of life assessment and reporting in phase III clinical trials of immune checkpoint inhibitors in solid cancers: A systematic review.
Servetto A; Salomone F; Di Costanzo F; Iuliano R; Marandino L; Napolitano F; Santaniello A; De Placido P; De Placido S; Di Maio M; Formisano L; Bianco R
Crit Rev Oncol Hematol; 2022 Apr; 172():103649. PubMed ID: 35259486
[TBL] [Abstract][Full Text] [Related]
19. Study protocol of the TRICOLORE trial: a randomized phase III study of oxaliplatin-based chemotherapy versus combination chemotherapy with S-1, irinotecan, and bevacizumab as first-line therapy for metastatic colorectal cancer.
Komatsu Y; Ishioka C; Shimada K; Yamada Y; Gamoh M; Sato A; Yamaguchi T; Yuki S; Morita S; Takahashi S; Goto R; Kurihara M
BMC Cancer; 2015 Sep; 15():626. PubMed ID: 26353772
[TBL] [Abstract][Full Text] [Related]
20. Informative censoring due to missing data in quality of life was inadequately assessed in most oncology randomized controlled trials.
Olivier T; Haslam A; Prasad V
J Clin Epidemiol; 2021 Nov; 139():80-86. PubMed ID: 34311054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
